Long-term cyclosporine treatment in a group of severe myasthenia gravis patients

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Michael J. Tocci, D A Matkovich, Kathy Collier et al. · The Journal of Immunology · 1989 · 669 citations

Cyclosporine for Plaque-Type Psoriasis

Charles N. Ellis, Mark S. Fradin, Joseph M. Messana et al. · New England Journal of Medicine · 1991 · 431 citations · Full text

Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia Gravis

Richard S. A. Tindall, JULIA A. ROLLINS, J. Theodore Phillips et al. · New England Journal of Medicine · 1987 · 388 citations

A Clinical Therapeutic Trial of Cyclosporine in Myasthenia Gravisa

Richard S. A. Tindall, J. Theodore Phillips, JULIA A. ROLLINS et al. · Annals of the New York Academy of Sciences · 1993 · 289 citations

Cyclosporine Group, Clinical Therapeutic, Medicine +11

EFFECT OF IMMUNOSUPPRESSIVE DRUGS (AZATHIOPRINE)

H. G. Mertens, G. Hertel, P. Reuther et al. · Annals of the New York Academy of Sciences · 1981 · 140 citations

Inflammation, Autoimmune Disease, Medicine +6